Research and Markets: Kuwait Pharmaceuticals and Healthcare Report Q4 2011

DUBLIN--(BUSINESS WIRE)--

Research and Markets(http://www.researchandmarkets.com/research/8fe7fa/kuwait_pharmaceuti) has announced the addition of the "Kuwait Pharmaceuticals and Healthcare Report Q4 2011" report to their offering.

Business Monitor International's Kuwait Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Kuwait's pharmaceuticals and healthcare industry.

BMI View: Kuwait's healthcare system is undergoing a period of transition from a primarily state-run public healthcare system to an increased number of public-private partnerships (PPPs), which should deliver both efficiency savings and better healthcare outcomes. The country already has one of the most advanced healthcare systems in the region and the establishment of a private health insurance sector presents huge opportunities for local and foreign companies. However, BMI cautions that the country's high population growth rate, a consequence of an influx of expatriate workers, will make it difficult for providers to keep up with demand.

BMI Economic View: Although the prospect of elevated oil prices have boosted BMIs revenue forecasts for Kuwait for the fiscal year 2011/2012, the recent increase in spending approved by parliament led BMI to revise down their projection for the country's budget surplus to 22.5% of GDP, from 30.2% previously.

BMI Political View: Although Kuwait is among those countries in the Middle East and North Africa (MENA) most insulated from large-scale unrest, some protest activity gathered momentum in late Q211, elevating concern of increased political risk. This comes on top of a new vote of no-confidence, which though survived by Prime Minister Sheikh Nasser al-Mohammed al-Sabah on June 23, indicates persisting tensions between the government and members of parliament.

Key Topics Covered:

1. SWOT Analysis

2. Pharmaceutical Business Environment Ratings

3. Kuwait - Market Summary

4. Regulatory Regime

5. Industry Developments

6. Industry Forecast Scenario

7. Competitive Landscape

8. Pharmaceutical Sector

9. Company Profiles

10. Country Snapshot: Kuwait Demographic Data

11. Glossary